The PML nuclear bodies: actors or extras?
- 30 June 1999
- journal article
- review article
- Published by Elsevier BV in Current Opinion in Genetics & Development
- Vol. 9 (3), 362-367
- https://doi.org/10.1016/s0959-437x(99)80054-9
Abstract
No abstract availableThis publication has 38 references indexed in Scilit:
- Complete Remission after Treatment of Acute Promyelocytic Leukemia with Arsenic TrioxideThe New England Journal of Medicine, 1998
- Structure, Organization, and Dynamics of Promyelocytic Leukemia Protein Nuclear BodiesAmerican Journal of Human Genetics, 1998
- Modulation of Fos-mediated AP-1 transcription by the promyelocytic leukemia proteinOncogene, 1998
- The acute promyelocytic leukaemia specific PML and PLZF proteins localize to adjacent and functionally distinct nuclear bodiesOncogene, 1998
- Distinct interactions of PML-RARα and PLZF-RARα with co-repressors determine differential responses to RA in APLNature Genetics, 1998
- A novel ubiquitin-specific protease is dynamically associated with the PML nuclear domain and binds to a herpesvirus regulatory proteinThe EMBO Journal, 1997
- Intranuclear Redistribution of SV40T, p53, and PML in a Conditionally SV40T-Immortalized Cell LineExperimental Cell Research, 1996
- PML-containing nuclear bodies: Their spatial distribution in relation to other nuclear componentsJournal of Cellular Biochemistry, 1996
- Targeting of adenovirus E1A and E4-ORF3 proteins to nuclear matrix-associated PML bodies.The Journal of cell biology, 1995
- Retinoic acid regulates aberrant nuclear localization of PML-RARα in acute promyelocytic leukemia cellsCell, 1994